The use of metabiotics in clinical geriatric practice (Guidelines of the Russian Association of Gerontologists and Geriatricians)
https://doi.org/10.37586/2686-8636-2-2026-164-174
Abstract
These guidelines examine the complex relationships between the gut microbiota and the aging process. They analyze the potential of therapeutic approaches aimed at microbiome correction through the use of metabiotics, presenting this as a promising strategy to increase both the lifespan and healthspan in geriatric populations. The advantages of incorporating metabiotics into the comprehensive therapy of certain diseases in elderly and senile patients are detailed.
About the Authors
A. A. Masharova
Pirogov Russian National Research Medical University (Pirogov Medical University), Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Moscow
M. S. Arefeva
Pirogov Russian National Research Medical University (Pirogov Medical University), Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Arefeva Mariia Sergeevna
Moscow
O. N. Tkacheva
Pirogov Russian National Research Medical University (Pirogov Medical University), Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Moscow
References
1. Hou Y., Dan X., Babbar M., et al. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 2019 ; 15 (10) : 565–581. DOI: 10.1038/s41582-019-0244-7.
2. Gyriki D., Nikolaidis C., Stavropoulou E., et al. Exploring the gut microbiome’s role in inflammatory bowel disease: insights and interventions. J. Pers. Med. 2024 ; 14 (5) : 507. DOI: 10.3390/jpm14050507.
3. Jandhyala S. M., Talukdar R., Subramanyam C., et al. Role of the normal gut microbiota. World J. Gastroenterol. 2015 ; 21 (29) : 8787–8803. DOI: 10.3748/wjg.v21.i29.8787.
4. Prosty C., Katergi K., Papenburg J., et al. Causal role of the gut microbiome in certain human diseases: a narrative review. eGastroenterology. 2024 ; 2 (3) : e100086. DOI: 10.1136/egastro-2024-100086.
5. Haran J. P., McCormick B. A. Aging, frailty, and the microbiome-how dysbiosis influences human aging and disease. Gastroenterology. 2021 ; 160 (2) : 507–523. DOI: 10.1053/j.gastro.2020.09.060.
6. Ardatskaya M. D., Belmer S. V., Dobritsa V. P., et al. Dysbiosis (dysbacteriosis) of the intestine: current state of the problem, comprehensive diagnosis and therapeutic correction. Experimental and Clinical Gastroenterology. 2015 ; 5 (117) : 13–50. (In Russ.).
7. Gyriki D., Nikolaidis C. G., Bezirtzoglou E., et al. The gut microbiota and aging: interactions, implications, and interventions. Front Aging. 2025 ; 6 : 1452917. DOI: 10.3389/fragi.2025.1452917.
8. Shenderov B. A., Sinitsa A. V., Zakharchenko M. M., Lang C. Metabiotics: Present State, Challenges and Perspectives. Cham: Springer Nature Switzerland AG; 2020. 122 p. DOI: 10.1007/978-3-030-34167-1.
9. Ivashkin V. T., Gorelov A. V., Abdulganieva D. I., et al. Guidelines of the Scientific Society for the Clinical Study of the Human Microbiome (NSCIM) and the Russian Gastroenterological Association (RGA) on the use of probiotics, prebiotics, synbiotics, metabiotics and functional foods enriched with them for the treatment and prevention of gastroenterological diseases in adults and children. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2024; 34 (4) : 113–136. (In Russ.). DOI: 10.22416/1382-4376-2024-117-312.
10. Claesson M. J., Cusack S., O’Sullivan O., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U. S. A. 2011 ; 108 (Suppl 1) : 4586–4591. DOI: 10.1073/pnas.1000097107.
11. Rinninella E., Raoul P., Cintoni M., et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019 ; 7 (1) : 14. DOI: 10.3390/microorganisms7010014.
12. Mariat D., Firmesse O., Levenez F., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009 ; 9: 123. DOI: 10.1186/1471-2180-9-123.
13. Biagi E., Nylund L., Candela M., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010 ; 5 (6) : e10667. DOI: 10.1371/journal.pone.0010667.
14. Odamaki T., Kato K., Sugahara H., et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016 ; 16 (1) : 90. DOI: 10.1186/s12866-016-0708-5.
15. Vaiserman A., Romanenko M., Piven L., et al. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol. 2020 ; 20 (1) : 221. DOI: 10.1186/s12866-020-01903-7.
16. Biagi E., Nylund L., Candela M., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010 ; 5 (6) : e10667. DOI: 10.1371/journal.pone.0010667.
17. López-Otín C., Blasco M. A., Partridge L., Serrano M., Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023 ; 186 (2) : 243–278. DOI: 10.1016/j.cell.2022.11.001.
18. Park S.-H., Kim K.-A., Ahn Y.-T., et al. Comparative analysis of gut microbiota in elderly people of urbanized towns and longevity villages. BMC Microbiol. 2015 ; 15 : 49. DOI: 10.1186/s12866-015-0386-8.
19. Yu X., Wu X., Qiu L., et al. Analysis of the intestinal microbial community structure of healthy and long-living elderly residents in Gaotian Village of Liuyang City. Appl Microbiol Biotechnol. 2015 ; 99 (21) : 9085–9095. DOI: 10.1007/s00253-015-6888-3.
20. Wu L., Zeng T., Zinellu A., Rubino S., Kelvin D. J., Carru C. A cross-sectional study of compositional and functional profiles of gut microbiota in Sardinian centenarians. mSystems. 2019 ; 4 (4) : e00325-19. DOI: 10.1128/mSystems.00325-19.
21. Liu P., Wang Y., Yang G., et al. The role of shortchain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. Pharmacol Res. 2021 ; 165 : 105420. DOI: 10.1016/j.phrs.2021.105420.
22. Sato Y., Atarashi K., Plichta D. R., et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021 ; 599 (7885) : 458–464. DOI: 10.1038/s41586-021-03832-5.
23. Salazar J., Durán P., Díaz M. P., et al. Exploring the relationship between the gut microbiota and ageing: a possible age modulator. Int J Environ Res Public Health. 2023 ; 20 (10) : 5845. DOI: 10.3390/ijerph20105845.
24. Brüssow H. Problems with the concept of gut microbiota dysbiosis. Microb Biotechnol. 2020 ; 13 (2) : 423–434. DOI: 10.1111/1751-7915.13479.
25. Dogra S. K., Doré J., Damak S. Gut microbiota resilience: definition, link to health and strategies for intervention. Front Microbiol. 2020 ; 11 : 572921. DOI: 10.3389/fmicb.2020.572921.
26. Liu F., Yin J., Wang J., Xu X. Food for the elderly based on sensory perception: A review. Curr Res Food Sci. 2022 ; 5 : 1550–1558. DOI: 10.1016/j.crfs.2022.09.014.
27. Woodmansey E. J., McMurdo M. E. T., Macfarlane G. T., Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotictreated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol. 2004 ; 70 (10) : 6113–6122. DOI: 10.1128/AEM.70.10.6113-6122.2004.
28. Koliada A., Syzenko G., Moseiko V., et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017 ; 17 (1) : 120. DOI: 10.1186/s12866-017-1027-1.
29. Wegierska A. E., Charitos I. A., Topi S., et al. The Connection Between Physical Exercise and Gut Microbiota: Implications for Competitive Sports Athletes. Sports Med. 2022 ; 52 (10) : 2355–2369. DOI: 10.1007/s40279-022-01696-x.
30. Yu L., Bi M., Xie L. Correlation Between Polypharmacy and Gut Microbiota Compositional Changes in Older People Who Were Treated with Multidrug Therapy. Rejuvenation Res. 2025 ; 28 (6) : 291–299. DOI: 10.1177/15491684251365971.
31. Jeffery I. B., Lynch D. B., O’Toole P. W. Composition and temporal stability of the gut microbiota in older persons. ISME J. 2016 ; 10 (1) : 170–182. DOI: 10.1038/ismej.2015.88.
32. Kim B.-S., Choi C. W., Shin H., et al. Comparison of the gut microbiota of centenarians in longevity villages of South Korea with those of other age groups. J Microbiol Biotechnol. 2019 ; 29 (3) : 429–440. DOI: 10.4014/jmb.1811.11023.
33. Zhu Q., Jiang S., Du G. Effects of exercise frequency on the gut microbiota in elderly individuals. Microbiologyopen. 2020 ; 9 (8) : e1053. DOI: 10.1002/mbo3.1053.
34. Conlon M. A., Bird A. R. The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2014 ; 7 (1) : 17–44. DOI: 10.3390/nu7010017.
35. Lutgendorff F., Akkermans L. M. A., Söderholm J. D. The role of microbiota and probiotics in stress-induced gastrointestinal damage. Curr Mol Med. 2008 ; 8 (4) : 282–298. DOI: 10.2174/156652408784533779.
36. Coman V., Vodnar D. C. Gut microbiota and old age: modulating factors and interventions for healthy longevity. Exp Gerontol. 2020 ; 141 : 111095. DOI: 10.1016/j.exger.2020.111095.
37. Ramirez J., Guarner F., Bustos Fernandez L., et al. Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol. 2020 ; 10 : 572912. DOI: 10.3389/fcimb.2020.572912.
38. Falony G., Joossens M., Vieira-Silva S., et al. Populationlevel analysis of gut microbiome variation. Science. 2016 ; 352 (6285) : 560–564. DOI: 10.1126/science.aad3503.
39. Hou K., Wu Z.-X., Chen X.-Y., et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022 ; 7 (1) : 135–228. DOI: 10.1038/s41392-022-00974-4.
40. Imhann F., Vich Vila A., Bonder M. J., et al. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut Microbes. 2017 ; 8 (4) : 351–358. DOI: 10.1080/19490976.2017.1284732.
41. Tian L., Huang C., Fu W., et al. Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota. Front Pharmacol. 2023 ; 14 : 1217306. DOI: 10.3389/fphar.2023.1217306.
42. World Gastroenterology Organisation. Probiotics and prebiotics. 2023. https://www.worldgastroenterology.org/guidelines/probiotics-and-prebiotics. Accessed March 15, 2026.
43. Davani-Davari D., Negahdaripour M., Karimzadeh M., et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019 ; 8 (3) : 92. DOI: 10.3390/foods8030092.
44. Swanson K. S., Gibson G. R., Hutkins R., et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020 ; 17 (11) : 687–701. DOI: 10.1038/s41575-020-0344-2.
45. Ma L., Tu H., Chen T. Postbiotics in human health: a narrative review. Nutrients. 2023 ; 15 (2) : 291. DOI: 10.3390/nu15020291.
46. Salminen S., Collado M. C., Endo A., et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021 ; 18 (9) : 649–667. DOI: 10.1038/s41575-021-00440-6.
47. Cicero A. F. G., Fogacci F., Bove M., et al. Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial. Eur J Nutr. 2021 ; 60 (2) : 655–663. DOI: 10.1007/s00394-020-02271-8.
48. Yang D., Ren D., Zhang Y., et al. The gut microbiota dysbiosis in geriatric multimorbidity: pharmacotherapeutic implications, pathophysiological mechanisms, and precision modulation strategies. Ageing Res Rev. 2026 ; 115 : 103023. DOI: 10.1016/j.arr.2026.103023.
49. Biswas I., Das Mohapatra P. K. Recent advancement in metabiotics: a consortium with bioactive molecules after fermentation by probiotic bacteria with multidisciplinary application potential and future solution in health sector. Bioresour Technol Rep. 2023 ; 23 (9): 101583. DOI: 10.1016/j.biteb.2023.101583
50. Jang H. J., Lee N. K., Paik H. D. A narrative review on the advance of probiotics to metabiotics. J Microbiol Biotechnol. 2024 ; 34 (3) : 487–494. DOI: 10.4014/jmb.2311.11023.
51. Nataraj B. H., Shivanna S. K., Rao P., Nagpal R., Behare P. V. Evolutionary concepts in the functional biotics arena: a minireview. Food Sci Biotechnol. 2021 ; 30 (4) : 487–496. DOI: 10.1007/s10068-020-00818-3.
52. Shenderov B. A. Gut indigenous microbiota and epigenetics. Microb Ecol Health Dis. 2012 ; 23 : 17195. DOI: 10.3402/mehd.v23i0.17195.
53. Sheflin A. M., Whitney A. K., Weir T. L. Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep. 2014 ; 16 (10) : 406. DOI: 10.1007/s11912-014-0406-0.
54. Caselli M., Vaira G., Calo G., et al. Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr. 2011 ; 2 (5) : 372–376. DOI: 10.3945/an.111.000604.
55. Shenderov B. A. Metabiotics: novel idea or natural development of probiotic conception. Microb Ecol Health Dis. 2013 ; 24. DOI: 10.3402/mehd.v24i0.20399.
56. Shaikh A. M., Sreeja V. Metabiotics and their health benefits. Int J Food Ferment Technol. 2017 ; 6 (1) : 11–23. DOI: 10.5958/2321-712X.2017.00002.3.
57. Tsai Y. C., Cheng L. H., Liu Y. W., et al. Gerobiotics: probiotics targeting fundamental aging processes. Biosci Microbiota Food Health. 2021 ; 40 (1) : 1–11. DOI: 10.12938/bmfh.2020-026.
58. Chen L. H., Huang S. Y., Huang K. C., et al. Lactobacillus paracasei PS23 decelerated age-related muscle loss by ensuring mitochondrial function in SAMP8 mice. Aging (Albany NY). 2019 ; 11 (2) : 756–770. DOI: 10.18632/aging.101782.
59. Serkova M. Yu., Bakulin I. G., Avalueva E. B., et al. Antibiotic-associated diarrhea. Practical issues of diagnosis and treatment in elderly and senile patients. Primary Health Care (Russian Federation). 2025 ; 2 (2) : 64–72. (In Russ.). DOI: 10.15829/3034-4123-2025-54.
60. Dukowicz A. C., Lacy B. E., Levine G. M. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007 ; 3 (2 ): 112–122.
61. Martyniak A., Wójcicka M., Rogatko I., et al. A comprehensive review of the usefulness of prebiotics, probiotics, and postbiotics in the diagnosis and treatment of small intestine bacterial overgrowth. Microorganisms. 2025 ; 13 (1) : 57. DOI: 10.3390/microorganisms13010057
62. Yoo J. Y., Kim S. S. Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Nutrients. 2016 ; 8 (3) : 173. DOI: 10.3390/nu8030173.
63. Musso G., Gambino R., Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care. 2010 ; 33 (10) : 2277–2284. DOI: 10.2337/dc10-0556.
64. Bauer K. C., Rees T., Finlay B. B. The gut microbiota-brain axis expands neurologic function: a nervous rapport. Bioessays. 2019 ; 41 (10) : 1800268. DOI: 10.1002/bies.201800268.
65. Cheng L. H., Liu Y. W., Wu C. C., et al. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. J Food Drug Anal. 2019 ; 27 (3) : 632–648. DOI: 10.1016/j.jfda.2019.01.002.
66. Takahashi S., Kawamura T., Kanda Y., et al. Activation of CD1d-independent NK1.1+ T cells in the large intestine by lactobacilli. Immunol Lett. 2006 ; 102 (1) : 74–78. DOI: 10.1016/j.imlet.2005.07.003.
67. Fukui M., Fujino T., Tsutsui K., et al. The tumorpreventing effect of a mixture of several lactic acid bacteria on 1,2-dimethylhydrazine-induced colon carcinogenesis in mice. Oncol Rep. 2001 ; 8 (5) : 1073–1078. DOI: 10.3892/or.8.5.1073.
68. Popova T. S., Tropskaya N. S., Chernen'kaya T. V., et al. Effect of the extract of Daigo lactic acid bacteria fermentation on the composition of the microflora and intestinal motor function in experimental dysbiosis. Transplantologiya. The Russian Journal of Transplantation. 2016 ; (4) : 39–47. (In Russ.).
69. Odashiro K., Fukata M., Saito K., et al. The effects of lactic acid bacteria-fermented soymilk extract on patients with colonic polyps: a randomized, double-blind, placebocontrolled pilot trial. J Integr Stud Diet Habits. 2014 ; 25 (1) :20–25. DOI: 10.2740/jisdh.25.20.
70. Fukuchi M., Sugita M., Banjo M., et al. The impact of a competitive event and the efficacy of a lactic acid bacteriafermented soymilk extract on the gut microbiota and urinary metabolites of endurance athletes: an open-label pilot study. PLoS One. 2022 ; 17 (1) : e0262906. DOI: 10.1371/journal.pone.0262906.
Review
For citations:
Masharova A.A., Arefeva M.S., Tkacheva O.N. The use of metabiotics in clinical geriatric practice (Guidelines of the Russian Association of Gerontologists and Geriatricians). Russian Journal of Geriatric Medicine. 2026;(2):164-174. (In Russ.) https://doi.org/10.37586/2686-8636-2-2026-164-174
Views:
479
JATS XML
Email this article 